plicamycin has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, M; Hosoda, W; Komori, K; Sakuma, K; Sasaki, E; Shimizu, Y; Yatabe, Y | 1 |
| Choi, MC; Choi, WH | 1 |
2 other study(ies) available for plicamycin and Disease Exacerbation
| Article | Year |
|---|---|
MYB mediates downregulation of the colorectal cancer metastasis suppressor heterogeneous nuclear ribonucleoprotein L-like during epithelial-mesenchymal transition.
Topics: Binding Sites; Cell Proliferation; Colorectal Neoplasms; Disease Progression; Down-Regulation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Knockout Techniques; Heterogeneous-Nuclear Ribonucleoproteins; HT29 Cells; Humans; Neoplasm Metastasis; Plicamycin; Promoter Regions, Genetic; Proto-Oncogene Proteins c-myb; Sp1 Transcription Factor; Transcription, Genetic; Transfection | 2021 |
Mithramycin A Alleviates Osteoarthritic Cartilage Destruction by Inhibiting HIF-2α Expression.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Cartilage, Articular; Cells, Cultured; Chondrocytes; Disease Progression; Enzyme Induction; Interleukin-1beta; Joints; Male; Matrix Metalloproteinases; Mice, Inbred C57BL; NF-kappa B; Osteoarthritis; Plicamycin; Sp1 Transcription Factor | 2018 |